Advanced non-small cell lung cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11864-001-0016-6.pdf
Reference47 articles.
1. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995, 311:899.
2. Helsing M, Bergman, Thaning L, Hero U, for the Joint Lung Cancer Study Group: Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicenter randomized phase III trial. Eur J Cancer 1998, 34:1036–1044.
3. Cullen MH, Billingham LJ, Woodroffe CM, et al.:Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J Clin Oncol 1999, 17:3188–3194. This large, randomized, phase III study should forever put to rest any question about the palliative importance of chemotherapy in NSCLC.
4. Mather D, Sullivan SD, Parasuraman TV: Beyond survival: economic analyses of chemotherapy in advanced, inoperable NSCLC. Oncology 1998, 12:199–209.
5. Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer. J Clin Oncol 1997, 15:2996–3018.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. I-125 seeds with chemotherapy for progressive non-small-cell lung cancer after first-line treatment: a meta-analysis;Journal of Cardiothoracic Surgery;2022-04-12
2. 125I Seed Promotes Apoptosis in Non-small Lung Cancer Cells via the p38 MAPK-MDM2-p53 Signaling Pathway;Frontiers in Oncology;2021-04-21
3. 125I Brachytherapy in Locally Advanced Nonsmall Cell Lung Cancer After Progression of Concurrent Radiochemotherapy;Medicine;2015-12
4. CT-guided implantation of radioactive 125I seed in advanced non-small-cell lung cancer after failure of first-line chemotherapy;Journal of Cancer Research and Clinical Oncology;2014-04-11
5. Minor Morphologic Abnormalities of Adrenal Glands at CT: Prognostic Importance in Patients with Lung Cancer;Radiology;2005-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3